Can Fite Biofarma Ltd (CANF)
1.95
-0.02
(-1.02%)
USD |
NYAM |
Apr 24, 16:00
1.95
0.00 (0.00%)
After-Hours: 20:00
Can Fite Biofarma Enterprise Value: 0.9091M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 0.9091M |
| April 22, 2024 | 0.959M |
| April 19, 2024 | 0.959M |
| April 18, 2024 | 0.9091M |
| April 17, 2024 | 0.8592M |
| April 16, 2024 | 1.458M |
| April 15, 2024 | 1.408M |
| April 12, 2024 | 1.558M |
| April 11, 2024 | 2.456M |
| April 10, 2024 | 2.805M |
| April 09, 2024 | 2.356M |
| April 08, 2024 | 3.055M |
| April 05, 2024 | 2.805M |
| April 04, 2024 | 2.706M |
| April 03, 2024 | 2.506M |
| April 02, 2024 | 2.281M |
| April 01, 2024 | 2.606M |
| March 28, 2024 | 2.157M |
| March 27, 2024 | 1.322M |
| March 26, 2024 | 0.9595M |
| March 25, 2024 | 1.005M |
| March 22, 2024 | 1.186M |
| March 21, 2024 | 1.005M |
| March 20, 2024 | 1.186M |
| March 19, 2024 | 0.9595M |
| Date | Value |
|---|---|
| March 18, 2024 | 1.005M |
| March 15, 2024 | 0.6875M |
| March 14, 2024 | 0.7782M |
| March 13, 2024 | 1.232M |
| March 12, 2024 | 0.7782M |
| March 11, 2024 | 1.277M |
| March 08, 2024 | 1.096M |
| March 07, 2024 | 0.8688M |
| March 06, 2024 | 0.7329M |
| March 05, 2024 | 0.5969M |
| March 04, 2024 | 0.7782M |
| March 01, 2024 | 0.7329M |
| February 29, 2024 | 0.7782M |
| February 28, 2024 | 0.5067M |
| February 27, 2024 | 0.5969M |
| February 26, 2024 | 0.5969M |
| February 23, 2024 | 0.4156M |
| February 22, 2024 | 0.5969M |
| February 21, 2024 | 0.3702M |
| February 20, 2024 | 0.4609M |
| February 16, 2024 | 0.4922M |
| February 15, 2024 | 0.5969M |
| February 14, 2024 | 0.3249M |
| February 13, 2024 | 0.2819M |
| February 12, 2024 | 0.3929M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.721M
Minimum
Apr 12 2023
41.86M
Maximum
Mar 16 2021
10.96M
Average
9.590M
Median
Enterprise Value Benchmarks
| Compugen Ltd | 126.58M |
| Pluri Inc | 22.13M |
| BioLine Rx Ltd | 17.68M |
| XTL Biopharmaceuticals Ltd | 11.80M |
| BiomX Inc | 15.41M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.652M |
| Revenue (Quarterly) | 0.155M |
| Total Expenses (Quarterly) | 1.989M |
| EPS Diluted (Quarterly) | -1.517 |
| Profit Margin (Quarterly) | -1.07K% |
| Earnings Yield | -153.8% |
| Normalized Earnings Yield | -153.85 |